Rayner's Sophi Phacoemulsification System, cleared by the FDA, is now available to US cataract surgeons, enhancing surgical ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones ...

The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President Trump said he would soon begin similar negotiations with health insurers. By ...

N4 Pharma ( (GB:N4P)) has shared an update. N4 Pharma has announced significant progress in its collaboration with the University of Strathclyde, focusing on the development of its Nuvec® gene ...

TEL AVIV, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (PRFX) today announced that its pharmaceutical division has completed an R&D assessment of LayerBio’s proprietary drop-less, ...

Ripple Therapeutics, a clinical-stage company developing polymer-free sustained release drug delivery systems, has entered into an evaluation and licensing option agreement with an affiliate of Bausch ...

The race to develop safer, longer lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. Eli Lilly’s move to acquire Adverum Biotechnologies ...

Big Pharma recently announced a marketing campaign posing as patient advocacy. The industry’s trade association and advocacy arm said it is spending hundreds of billions of dollars to develop drugs ...

As U.S. production investments continue to roll in this year, German pharmaceutical technology specialist LTS Lohmann is joining the fray with a deal to boost its CDMO firepower in the States. Like ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...